D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 99 Citations 38,156 491 World Ranking 430 National Ranking 13
Medicine D-index 99 Citations 38,331 507 World Ranking 5105 National Ranking 150

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Internal medicine
  • DNA

Stephen Locarnini mainly investigates Virology, Hepatitis B virus, Hepatitis B, Immunology and Lamivudine. In his work, Drug is strongly intertwined with Drug resistance, which is a subfield of Virology. His Hepatitis B virus research is within the category of Virus.

His Hepatitis B study incorporates themes from Viral hepatitis, Intensive care medicine, Hepatitis, Public health and Alanine transaminase. The Immunology study combines topics in areas such as Internal medicine and Liver biopsy. His biological study spans a wide range of topics, including Nucleoside analogue, Combination therapy, Transplantation and Reverse-transcriptase inhibitor.

His most cited work include:

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
  • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. (843 citations)
  • Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes (740 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Virology, Hepatitis B virus, Hepatitis B, Immunology and Virus. In his research, Antiviral drug is intimately related to Drug resistance, which falls under the overarching field of Virology. His study in Hepatitis B virus is interdisciplinary in nature, drawing from both Viral load and Genotype.

His Hepatitis B study combines topics in areas such as Gastroenterology, Liver disease, Hepatocellular carcinoma and Viral hepatitis. His Virus study results in a more complete grasp of Genetics. His Lamivudine research incorporates elements of Nucleoside analogue, Famciclovir and Reverse-transcriptase inhibitor.

He most often published in these fields:

  • Virology (68.51%)
  • Hepatitis B virus (48.71%)
  • Hepatitis B (37.82%)

What were the highlights of his more recent work (between 2014-2021)?

  • Hepatitis B virus (48.71%)
  • Hepatitis B (37.82%)
  • Virology (68.51%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Hepatitis B virus, Hepatitis B, Virology, HBsAg and Immunology. His studies in Hepatitis B virus integrate themes in fields like Hepatocellular carcinoma, Viral load and Chronic infection. Stephen Locarnini combines subjects such as Global health, HBeAg, Serology and Intensive care medicine with his study of Hepatitis B.

His Virology research integrates issues from RNA interference, Antigen and Genotype. His study on HBsAg also encompasses disciplines like

  • Seroconversion that intertwine with fields like Adefovir and Combination therapy,
  • Gastroenterology that intertwine with fields like Entecavir and Tenofovir. His Immunology research incorporates themes from Biomarker and Liver cancer.

Between 2014 and 2021, his most popular works were:

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (1023 citations)
  • Present and future therapies of hepatitis B: From discovery to cure (193 citations)
  • RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg (176 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • DNA
  • Internal medicine

Stephen Locarnini spends much of his time researching Hepatitis B, Hepatitis B virus, Virology, Immunology and Internal medicine. His research in Hepatitis B intersects with topics in Epidemiology, Circular DNA, HBeAg and Global health, Public health. His Hepatitis B virus research is multidisciplinary, relying on both Hepatocellular carcinoma, Combination therapy, Genotype and Intensive care medicine.

The study incorporates disciplines such as Genetics and Antigen in addition to Virology. His Immunology research includes themes of Cirrhosis and Therapy naive. Stephen Locarnini has included themes like Gastroenterology, Oncology and Family medicine in his Internal medicine study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas.
Hepatology International (2016)

1902 Citations

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

Yun Fan Liaw;Jia Horng Kao;Teerha Piratvisuth;Henry Lik Yuen Chan.
Hepatology International (2012)

1190 Citations

Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy

Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn.
Gastroenterology (2004)

1130 Citations

Genetic Diversity of Hepatitis B Virus Strains Derived Worldwide: Genotypes, Subgenotypes, and HBsAg Subtypes

Helene Norder;Anne-Marie Couroucé;Pierre Coursaget;José M Echevarria.
Intervirology (2004)

1101 Citations

Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)

1063 Citations

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase

Peter W Angus;Rhys B Vaughan;Shelly Xiong;Huiling Yang.
Gastroenterology (2003)

798 Citations

Clinical Emergence of Entecavir-Resistant Hepatitis B Virus Requires Additional Substitutions in Virus Already Resistant to Lamivudine

D J Tenney;S M Levine;R E Rose;A W Walsh.
Antimicrobial Agents and Chemotherapy (2004)

750 Citations

Molecular virology of hepatitis B virus.

Stephen Locarnini.
Seminars in Liver Disease (2004)

723 Citations

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatology (2007)

677 Citations

Hepatitis B virus resistance to nucleos(t)ide analogues.

Fabien Zoulim;Fabien Zoulim;Stephen Locarnini.
Gastroenterology (2009)

607 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stephen Locarnini

Fabien Zoulim

Fabien Zoulim

Inserm

Publications: 290

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 126

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 113

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 106

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 102

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 101

Yasuhito Tanaka

Yasuhito Tanaka

Kumamoto University

Publications: 90

Grace Lai-Hung Wong

Grace Lai-Hung Wong

Chinese University of Hong Kong

Publications: 89

Pei-Jer Chen

Pei-Jer Chen

National Taiwan University

Publications: 88

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 88

Mengji Lu

Mengji Lu

University of Duisburg-Essen

Publications: 86

Vincent Wai-Sun Wong

Vincent Wai-Sun Wong

Chinese University of Hong Kong

Publications: 79

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 77

Sang Hoon Ahn

Sang Hoon Ahn

Yonsei University

Publications: 77

David Durantel

David Durantel

Inserm

Publications: 74

Jinlin Hou

Jinlin Hou

Southern Medical University

Publications: 73

Trending Scientists

Venkat Anantharam

Venkat Anantharam

University of California, Berkeley

Liancun Zheng

Liancun Zheng

University of Science and Technology Beijing

Nian X. Sun

Nian X. Sun

Northeastern University

Tetsuhiro Ishikawa

Tetsuhiro Ishikawa

Toyota Motor Corporation (Switzerland)

Bernd Jastorff

Bernd Jastorff

University of Bremen

John P. Richard

John P. Richard

University at Buffalo, State University of New York

Arnd Garsuch

Arnd Garsuch

BASF (United States)

Yalin Lu

Yalin Lu

University of Science and Technology of China

Paul A. Tyler

Paul A. Tyler

University of Southampton

Kristof Van Oost

Kristof Van Oost

Université Catholique de Louvain

Prasad S. Thenkabail

Prasad S. Thenkabail

United States Geological Survey

Anna Devor

Anna Devor

Boston University

Oliver C. Schultheiss

Oliver C. Schultheiss

University of Erlangen-Nuremberg

Anne D. Simons

Anne D. Simons

University of Notre Dame

Lisette Schoonhoven

Lisette Schoonhoven

Utrecht University

Peter J. Burnell

Peter J. Burnell

University of Warwick

Something went wrong. Please try again later.